Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis (the European Breast Guidelines) for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before publication are subject of open calls for feedback launched online.

The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care). 

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Privacy statement

Members and external experts

Solveig Hofvind

Solveig Hofvind

Head of the Norwegian Breast Cancer Screening Program, professor in radiography at Oslo and Akershus University College of Applied Sciences.

Hofvind is radiographer by training and did her master at the Norwegian school of sport sciences (Physical activity and risk of breast cancer).

After 13 years work at Akershus University hospital, where she was the pioneer in establishing a breast clinic and the Norwegian Breast Cancer Screening Program, she started to work at the Cancer Registry of Norway. The Cancer Registry is responsible for the administration and quality assurance of the screening program. Hofvind started working as an information advices for the breast and cervical cancer screening programs in 1998. Four years later she started working on her PhD, which she finished in 2005 (The Norwegian Breast Cancer Screening Program: Selected process indicators and their utilization in epidemiological research).

Hofvind was guest professor at the University of Vermont, 2006-07, and 2010-11 and a substantial network internationally.

She has about 90 peer-review publications, mainly related to epidemiological aspects of breast cancer and mammographic screening.

Declaration of interests



Last update: 2018